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Dietary and Physical Activity 
Interventions for Colorectal 
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Antoinette M. Lee5, Sharron Leung6, Wynnie Y. Y. Chan7, Ivy P. F. Leung8, Sharon H. S. Lam2, 
Natural Chu2, Aliki J. Taylor9 & Kar-keung Cheng  9
There has been evidence on the protective effects of diets high in fiber and low in red and processed 
meat (RPM), and physical activity (PA) against colorectal cancer (CRC) development, but that against 
CRC recurrence has been limited. This study evaluated the efficacy of a behavioral program comprising 
dietary and PA interventions in improving Chinese CRC survivors’ lifestyle. A 2 × 2 factorial randomized 
controlled trial of 223 CRC patients (82 females, mean age 65), randomly assigned to receive dietary, 
PA or both interventions, or usual care for 12 months, and assessed every 6 months for 24 months. 
Primary outcomes included two dietary and two PA targets. Secondary outcomes included changes in 
dietary consumptions and PA levels. Dietary interventions significantly increased the odds of achieving 
the targets of consuming less RPM at all time-points (OR 3.22–4.57, all p < 0.01) and refined grain (RG) 
at months 6 (OR 3.13, p = 0.002) and 24 (OR 2.19, p = 0.039), and reduced RPM (2.49–3.48 servings/
week, all p < 0.01) and RG (0.31–0.5 servings/day, all p < 0.01) consumptions. Patients receiving PA 
interventions potentially spent more time on moderate-to-vigorous PA. This study demonstrated the 
efficacy of a behavioral program in improving dietary habits of Chinese CRC survivors.
Colorectal cancer (CRC) was the third most common cancer type and the fourth largest cause of cancer mortality 
in the world, with 1.4 million new cases and almost 700,000 deaths in 20121. In Hong Kong, CRC was ranked first 
and second by incidence and mortality, respectively, in 20142. These figures called for effective interventions that 
would prevent CRC and improve cancer outcomes in survivors.
The World Cancer Research Fund summarized evidence from observational studies and concluded that 
low dietary fiber, and high red and processed meat (RPM) intakes were associated with higher risk of CRC, 
whilst physical activity (PA) protected against developing colon cancer3. Importantly, dietary control and PA are 
non-pharmacological and non-invasive interventions that appeal to CRC patients who have had invasive cancer 
treatments. However, only a few randomized controlled trials (RCTs) have evaluated the efficacy of behavioral 
interventions in modifying the dietary and PA habits of CRC survivors. In 2011, a meta-analysis of RCTs on PA 
for cancer survivors identified only 3, out of 34 studies, that evaluated PA in solely CRC or colon cancer survi-
vors4. Two RCTs of both PA and dietary interventions for CRC survivors have been subsequently conducted in 
the United States and Australia5,6. Also, a pilot RCT comparing two home-based PA interventions in Korean CRC 
survivors has been reported7.
All these RCTs assessed only short-term effects at 12 weeks to 12 months post-intervention. In addition, with 
the exception of one7, they were primarily conducted in Caucasian populations5,6,8–10 and none targeted a Chinese 
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population. Lifestyle can vary drastically across countries due to differences in culture, infrastructure and eco-
nomic situations. When compared with the West, Chinese societies have their unique culture with distinct lifestyle 
habits. For instance, Chinese traditionally share the main dishes in a meal with others rather than having their own 
portions. Hence, modifying dietary habits in Chinese would likely be more complex. Differences can also be found 
in PA, as in Chinese societies public transport (involving a certain amount of walking to/from transit points) is the 
main modality of transport11, whilst private cars are more common in North America12. These lifestyle differences 
necessitate the need for evaluating behavioral interventions specifically in a Chinese population.
Before assessing the efficacy of behavioral interventions on cancer outcomes, we have to assess whether the 
interventions may effectively modify the targeted behaviors. Therefore, we aimed to evaluate whether the dietary 
and PA interventions of the “Moving Bright, Eating Smart” program are effective in reducing the consumption of 
RPM and refined grain (RG), and increasing the PA levels in adult Chinese CRC survivors.
Results
Baseline characteristics. Between 1st May 2013 and 30th April 2014, 229 eligible patients consented to par-
ticipate in the study (Fig. 1). After randomization, 3 patients dropped out before commencing any intervention 
and another 3 patients were excluded due to active psychiatric illness, not residing in Hong Kong, and hereditary 
CRC syndrome. As a result, 223 patients received the assigned interventions. At 24 months, 192 patients com-
pleted the interventions and follow-up. Thirty-one patients dropped out from the trial due to cancer recurrence 
(n = 18, Group A: 4, Group B: 6, Group C: 2, Group D: 6), loss to follow-up (n = 8, Group A: 2, Group B: 3, Group 
C: 2, Group D: 1) and development of new cancer (n = 5, Group A: 2, Group B: 1, Group C: 1, Group D: 1). Two 
patients with CRC recurrence died from the disease. There were only 4 patients at stage IV and thus they were 
combined with the other 80 patients at stage III. All patients had surgery with 129 (57.8%) received adjuvant 
chemotherapy and 43 (19.3%) received adjuvant/neoadjuvant radiotherapy.
These 223 patients had a mean age of 65.2 years (standard deviation = 10.1; range = 25 to 86), and 82 (36.8%) 
of them were females. There were 133 (59.6%) patients with colon cancer, 89 (39.9%) with rectal cancer, and one 
(0.4%) with synchronous colon and rectal cancers. No significant differences in baseline characteristics among the 
four groups were observed (Table 1). Patients in Groups A, B and C attended an average of 94.6% of all sessions of 
motivational interviews, answered 72.4% of the motivational phone calls, and joined 43.5% of the group meetings.
Achieving behavioral targets. Between 52.3% and 60.4% of the patients receiving the dietary interven-
tions (Group A + B) met the RPM target (Table 2), compared to 25.9% to 31.3% of those not receiving the die-
tary interventions (Group C + D). There was no significant interaction effect among the dietary interventions, 
PA interventions and time. The overall effect of the dietary interventions on the RPM target was significant 
(p < 0.001), with an odds ratio (OR) of 3.88 (95% CI = 2.32–6.50). The effects of the dietary intervention were 
also significant at all time-points, with ORs between 3.22 and 4.57. For the RG target, the overall OR was 1.90 
(1.18–3.07, p = 0.008), and significant intervention effects were also observed at months 6 (OR = 3.13 [1.51–6.48], 
p = 0.002) and 24 (OR = 2.19 [1.04–4.63], p = 0.039). When comparing Group A + C with Group B + D, PA inter-
ventions showed significant positive effects on the general health target overall (OR = 1.94 [1.10–3.40], p = 0.022) 
and at month 12 (OR = 2.45 [1.10–5.43], p = 0.028), as well as significant positive effects on the cancer outcome 
target overall (OR = 1.95 [1.13–3.35], p = 0.016) and at month 18 (OR = 2.38 [1.08–5.23], p = 0.018). When miss-
ing values were imputed using multiple imputation, the dietary-intervention effects remained the same, but the 
PA-intervention effects became insignificant. The numbers meeting the targets in each group are presented in 
Supplementary Table 1.
Magnitude change in dietary intake and PA level. All four groups had reduced intakes of RPM and 
RG and improvement in PA level at all time-points from baseline (Supplementary Table 2). The only exception 
was an increase in RPM consumption in Group C at month 18. Patients who underwent the dietary interventions 
showed significantly larger reductions in RPM intakes by 2.49 to 3.48 servings per week (p < 0.001) and RG 
intakes by 0.31 to 0.50 servings per day (p ≤ 0.005) when compared with those who did not receive the inter-
ventions (Table 3). The PA interventions were not significantly associated with any change in PA levels, although 
patients receiving the PA interventions spent 3.3 to 73.1 more minutes/week on MVPA at all time-points.
In the subgroup of 49 patients who had <300 minutes of MVPA per week at baseline, PA interventions did 
not significantly improve the two PA targets (Table 4). However, patients who received the PA interventions 
had significantly larger increases in PA at months 6 (difference = 174.2, [34.7–313.7], p = 0.015) and 18 (179.0 
[36.6–321.3], p = 0.014) than those who did not receive the PA interventions.
Adverse events. At month 6, dietary interventions reduced mean daily caloric intake (−93 calories [−185-
−0.5], p = 0.049), while at month 18 (Supplementary Table 3). Other than this, the dietary interventions had 
no significant impact on the daily caloric intake, daily protein intake and hemoglobin level at all assessment 
time-points. PA-associated injuries were rare in the PA intervention groups with minimal ill-effect.
Discussion
Our theory-driven behavioral program was the first of its kind for Chinese CRC patients, which showed clear 
efficacy in reducing the intake of RPM over the 24-month study period without causing dietary deficiency or 
dietary-associated anemia. This study also demonstrated improvement in intake of refined grain by the dietary 
interventions, and increased PA level by the PA interventions, though the effects were not consistently significant 
over time. Moreover, the lack of interaction effects between dietary and PA interventions made it possible to 
capitalize on the statistical power gained from the factorial design assessing the intervention effects. The findings 
are expected to be generalizable as the CRC patients’ characteristics were similar to those reported in previous 
local studies13,14.
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It is encouraging to observe a significantly higher proportion of CRC survivors achieving the dietary targets 
and greater reductions of RPM and RG intakes through dietary interventions. Moreover, the differences observed 
were clinically important and sustainable for at least 24 months. There has been an old Chinese saying that “dis-
ease enters by the mouth”. The concept of disease prevention and health improvement by dietary modification 
is imprinted in the Chinese culture. Our CRC survivors were more than willing to receive dietary advices after 
definitive cancer therapy for improving their general health status and optimizing their cancer outcomes. In 
line with this understanding, our dietary interventions aimed to provide knowledge on the types of food that 
would affect CRC outcomes and to provide practical information on how to achieve the suggested dietary targets. 
Figure 1. The CONSORT flowchart of the 223 colorectal cancer survivors participating in this trial.
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Characteristic
Group A
Dietary & PA
(n = 55)
Group B
Dietary only
(n = 56)
Group C
PA only
(n = 56)
Group D
Usual care
(n = 56)
PNo. % No. % No. % No. %
Age, years (mean, SD) 63.2 11.4 65.9 9.8 66.6 9.5 64.9 9.4 0.324
Sex 0.221
  Male 37 67.3 34 60.7 40 71.4 30 53.6
  Female 18 32.7 22 39.3 16 28.6 26 46.4
Education level 0.238
  High school or below 7 12.7 6 10.7 11 19.6 4 7.1
  College or above 48 87.3 50 89.3 45 80.4 52 92.9
Care giver 0.875
  Self 35 63.6 35 62.5 39 69.6 39 69.6
  Spouse 12 21.8 15 26.8 13 23.2 11 19.6
  Others 8 14.5 6 10.7 4 7.1 6 10.7
Monthly household income† 0.422
  ≤HK$10,000 21 38.2 18 32.1 20 35.7 15 26.8
  HK$10,000-HK$25,000 12 21.8 11 19.6 12 21.4 22 39.3
  >HK$25,000 19 34.5 23 41.1 19 33.9 17 30.4
Cancer site 0.589
  Colon 35 63.6 34 60.7 29 51.8 35 62.5
  Rectum 20 36.4 22 39.3 26 46.4 21 37.5
  Colon and rectum 0 0.0 0 0.0 1 1.8 0 0.0
AJCC tumor stage 0.407
  Stage I 14 25.9 9 16.1 8 14.5 12 21.4
  Stage II 24 44.4 20 35.7 27 49.1 24 42.9
  Stage III or IV 16 29.6 27 48.2 20 36.4 20 35.7
Cigarette smoking status 0.684
  Never-smoker 39 70.9 41 73.2 37 66.1 42 75.0
  Ex-smoker 14 25.5 10 17.9 16 28.6 10 17.9
  Current smoker 2 3.6 5 8.9 3 5.4 4 7.1
Alcohol drinking habit 0.818
  Never drinker 31 56.4 30 53.6 32 57.1 38 67.9
  Ex-drinker 17 30.9 17 30.4 16 28.6 12 21.4
  Current drinker 7 12.7 9 16.1 8 14.3 6 10.7
Hypertension 18 32.7 28 50.0 20 35.7 22 39.3 0.264
Ischemic heart disease 1 1.8 5 8.9 6 10.7 2 3.6 0.165
Diabetes mellitus 8 14.5 13 23.2 6 10.7 9 16.1 0.335
Chronic respiratory diseases 3 5.5 2 3.6 0 0.0 3 5.4 0.370
Chronic renal disease 2 3.6 0 0.0 1 1.8 1 1.8 0.555
Cerebrovascular accident 2 3.6 2 3.6 0 0.0 1 1.8 0.517
Stoma status 0.922
  No stoma 47 85.8 48 85.7 48 85.7 50 89.3
  Permanent or temporary sotma 8 14.5 8 14.3 8 14.3 6 10.7
Body weight, kg (mean, SD) 62.9 12.0 62.1 11.0 61.8 10.4 61.3 10.7 0.893
BMI, kg/m2 (mean, SD) 23.8 3.3 24.0 3.2 23.8 3.1 23.9 3.6 0.987
Caloric intake, Kcal (mean, SD) 1530 400 1548 429 1518 367 1520 477 0.979
Dietary & PA targets
RPM intake, servings/week (mean, SD) 9.2 6.5 8.3 5.0 7.7 4.3 8.8 7.1 0.547
RG intake, servings/day (mean, SD) 3.0 1.1 2.7 0.9 2.8 1.1 2.7 0.8 0.438
Accumulated MVPA, minutes/week (mean, SD) 534.2 329.3 498.1 316.8 460.8 239.6 473.3 267.3 0.597
Meeting red/processed meat target 14 25.5 16 28.6 10 17.9 16 28.6 0.516
Meeting refined grain target 6 10.9 7 12.5 7 12.5 5 8.9 0.922
Meeting PA general health target 47 85.5 46 82.1 46 82.1 50 89.3 0.980
Meeting PA cancer outcome target 41 74.5 34 60.7 37 66.1 42 75.0 0.614
Table 1. Patient characteristics at baseline. Abbreviations: PA, physical activity; SD, standard deviation; AJCC, 
American Joint Committee on Cancer. †Exchange rate: US$1 = HK$7.8.
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Personal interactions with the dietary coach through face-to-face interviews and fortnightly phone calls were 
welcomed by our patients as means of moral support and trouble-shooting.
This study revealed a larger reduction of RPM than RG intake. Under the staggered approach of the dietary 
interventions, RPM was the first target and thus the patients had more time to modify their RPM intake. Also, 
reducing beef and mutton is easy for CRC survivors as the former is believed to be toxic in the traditional Chinese 
medicine theory and the latter is not commonly eaten. Pork is the main red meat in Chinese diet. However, in 
Hong Kong and most part of China, there are many alternative protein sources including poultry, seafood (espe-
cially fish which is traditional Chinese diet), and a wide choice of pulses such as tofu and its derived products. 
In contrast, while white rice is the staple food of southern Chinese people, the whole grain alternatives such as 
brown and red rice are uncommon and more expensive.
Our PA interventions did not yield a significant improvement in CRC survivors’ PA levels. A possible reason 
was that the patients’ PA levels at baseline were already high, leaving little room for improvement. At baseline, 
only 49 patients had <300 minutes/week of MVPA, and the other 145 patients had between 300 and 1000 min-
utes/week of MVPA. These 145 patients grossly underestimated their PA levels when they self-completed the 
GPAQ at baseline, otherwise they could have been excluded from the study. Indeed, another study in Hong 
Kong that used a similar questionnaire also reported that urban older adults tended to under-report their PA 
levels when compared to objective accelerometer measurements15. Hong Kong has been objectively shown to 
have an extremely high “walkability score,”16 thus residents can accumulate substantial amounts of PA through 
walking17,18. In this regards, a recent study found that Hong Kong older adults accumulated on average 182 min-
utes/week of accelerometer-measured MVPA defined using cut-points developed on young Caucasians19. As 
these cut-points substantially underestimate PA in older adults, this study suggested that a large proportion 
Outcomes† % of patients meeting the target OR (95% CI) P
Dietary targets Groups A + B Groups C + D Dietary interventions
Red/processed meat target
Baseline 27.0 23.2 1.19 (0.55 to 2.58) 0.661
Month 6 53.2 25.9 4.24 (1.96 to 9.17) <0.001
Month 12 55.0 29.5 3.73 (1.74 to 7.97) <0.001
Month 18 60.4 31.3 4.57 (2.14 to 9.76) <0.001
Month 24 52.3 29.5 3.22 (1.50 to 6.89) 0.003
Overall‡ 49.5 27.9 3.88 (2.32 to 6.50) <0.001
Refined grain target
Baseline 11.7 10.7 1.11 (0.41 to 3.02) 0.837
Month 6 51.4 30.4 3.13 (1.51 to 6.48) 0.002
Month 12 43.2 33.9 1.62 (0.79 to 3.35) 0.188
Month 18 39.6 35.7 1.20 (0.58 to 2.47) 0.623
Month 24 40.5 26.8 2.19 (1.04 to 4.63) 0.039
Overall‡ 37.3 27.5 1.90 (1.18 to 3.07) 0.008
PA targets Groups A + C Groups B + D PA interventions
PA general health target
Baseline 83.8 85.7 0.81 (0.31 to 2.09) 0.658
Month 6 73.0 64.3 1.81 (0.78 to 4.17) 0.166
Month 12 62.2 47.3 2.45 (1.10 to 5.43) 0.028
Month 18 67.6 56.3 2.04 (0.91 to 4.59) 0.085
Month 24 64.0 57.1 1.53 (0.68 to 3.44) 0.299
Overall‡ 70.1 62.1 1.94 (1.10 to 3.40) 0.022
PA cancer outcome target
Baseline 70.3 67.9 1.14 (0.52 to 2.50) 0.739
Month 6 68.5 57.1 1.90 (0.85 to 4.24) 0.116
Month 12 55.0 43.8 1.77 (0.81 to 3.86) 0.151
Month 18 64.0 48.2 2.38 (1.08 to 5.23) 0.031
Month 24 60.4 49.1 1.83 (0.83 to 4.02) 0.134
Overall‡ 63.6 53.2 1.95 (1.13 to 3.35) 0.016
Table 2. Effects of dietary and physical activity interventions on achieving the behavioral targets at various 
time points. Abbreviations: PA, physical activity; OR, odds ratio; CI, confidence intervals. †Red/processed meat 
target: <5 servings of red and processed meat per week, including <2 servings of processed meat. Refined grain 
target: <2 servings of refined grain per day. PA general health target ≥30 minutes of moderate-to-vigorous 
intensity physical activity (MVPA) 5 days a week. PA cancer outcome target ≥60 minutes of MVPA 5 days a 
week. ‡The “overall” comparison was a test for the effect of the interventions at all follow-up time points (four 
levels at 6, 12, 18 and 24 months) using repeated measures mixed effects models, where the time point were 
regarded as a categorical variable.
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of Hong Kong older adults exceed the PA recommendation of 150 minutes/week as defined by accelerometry. 
Excluding the physically active patients at baseline indeed substantially increased the PA effects although the 
effects remained statistically non-significant because of insufficient power. Future research that focuses on less 
physically active patients is therefore warranted.
Our patients generally complied with the assigned interventions. The interventions consisted mainly of 
face-to-face motivational interviews with attendance rate of over 90%, quarterly group meetings attended by 
43.5% of patients, and fortnightly phone calls with successful contact rate of 72.4%. These were accomplished 
with persistent efforts to follow the study patients by the intervention coaches. The relatively low attendance rate 
Outcomes Mean (SD)
Difference in change 
from baseline (95% CI) P
Dietary targets Groups A + B Groups C + D Dietary interventions
Red and processed meat intake (servings/week)
Baseline 8.7 (5.8) 8.2 (5.9)
Month 6 4.3 (4.0) 7.3 (5.8) −2.81 (−4.02 to −1.61) <0.001
Month 12 3.8 (3.8) 7.0 (4.7) −3.48 (−4.65 to −2.31) <0.001
Month 18 4.5 (4.4) 7.7 (5.7) −2.49 (−3.68 to −1.30) <0.001
Month 24 4.6 (3.6) 7.0 (4.5) −2.94 (−3.90 to −1.97) <0.001
Refined grain intake (servings/day)
Baseline 2.8 (1.0) 2.7 (0.9)
Month 6 1.9 (0.8) 2.5 (1.1) −0.50 (−0.72 to −0.27) <0.001
Month 12 2.0 (0.9) 2.4 (1.0) −0.31 (−0.52 to −0.09) 0.005
Month 18 2.1 (0.8) 2.3 (0.9) −0.38 (−0.60 to −0.17) <0.001
Month 24 2.0 (0.7) 2.4 (0.8) −0.45 (−0.62 to −0.29) <0.001
PA targets Groups A + C Groups B + D PA interventions
PA level (accumulated minutes/week of MVPA)
Baseline 498.2 (289.8) 485.1 (290.7)
Month 6 660.6 (317.5) 612.4 (325.8) 21.6 (−61.1 to 104.3) 0.607
Month 12 594.7 (238.3) 578.4 (291.4) 10.1 (−78.2 to 98.3) 0.823
Month 18 681.8 (309.7) 643.8 (387.6) 3.3 (−81.7 to 88.3) 0.939
Month 24 705.0 (324.0) 613.3 (321.4) 73.1 (−12.5 to 158.8) 0.094
Table 3. Effects of dietary and physical activity interventions on changes of dietary consumption and physical 
activity level. Abbreviations: SD, standard deviation; PA, physical activity; CI, confidence intervals; MVPA, 
moderate-to-vigorous intensity physical activity.
Outcomes†
PA interventions
PA-intervention effectsReceived (n = 22) Not received (n = 27)
No. (%) of patients meeting the target Odds ratio (95% CI) P
PA general health target
Month 6 15 (68.2) 17 (63.0) 1.67 (0.31 to 9.09) 0.551
Month 12 12 (54.5) 11 (40.7) 4.99 (0.91 to 27.46) 0.065
Month 18 15 (68.2) 14 (51.9) 1.83 (0.33 to 9.98) 0.484
Month 24 15 (68.2) 16 (59.3) 1.39 (0.26 to 7.54) 0.702
PA cancer outcome target
Month 6 13 (59.1) 12 (44.4) 2.22 (0.45 to 10.92) 0.324
Month 12 8 (36.4) 9 (33.3) 1.94 (0.37 to 10.15) 0.430
Month 18 13 (59.1) 6 (22.2) 4.84 (0.93 to 25.28) 0.062
Month 24 11 (50.0) 10 (37.0) 1.71 (0.34 to 8.73) 0.515
Mean (SD) change in PA level Estimated coefficient (95% CI) P
Change in PA level (accumulated minutes of MVPA per week)
Month 6 305.0 (319.5) 120.0 (114.1) 174.2 (34.7 to 313.7) 0.015
Month 12 199.3 (180.3) 93.8 (112.8) 114.1 (−32.2 to 260.5) 0.125
Month 18 291.0 (252.6) 78.5 (106.4) 179.0 (36.6 to 321.3) 0.014
Month 24 263.4 (254.1) 151.8 (174.5) 89.9 (−50.4 to 230.2) 0.206
Table 4. Subgroup analysis of patients who did not meet the target of physical activity cancer outcome 
at baseline. Abbreviations: PA, physical activity; CI, confidence intervals; SD, standard deviation; MVPA, 
moderate-to-vigorous intensity physical activity. †PA general health target: ≥30 minutes of MVPA 5 days a 
week. PA cancer outcome target: ≥60 minutes of MVPA 5 days a week.
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of group meetings reflected our patients’ reluctance in making extra-visits to the participating hospitals, and 
their preference for the individual rather than the group intervention modality. One possible way to improve the 
attendance would be to schedule the group meetings and patients’ clinic visits in succession on the same days.
There have been studies reporting the protective effects of dietary and PA interventions on the development 
of CRC. However, the relationship between these behavioral change and cancer recurrence had not been well 
studied. The behavioral interventions evaluated in this study are complex; for which evaluation guidelines rec-
ommended the importance of assessing their feasibility20. This has been demonstrated in this study, and future 
studies can further investigate the effects of the interventions on cancer outcomes.
This study has some limitations. First, assessing patients’ eligibility by self-reported GPAQ may underestimate 
the actual baseline PA levels. Future studies may consider alternative approaches, e.g. the use of accelerometers 
or pedometers to confirm the patient’s eligibility. Second, it was difficult to gather the patients for the group 
meetings. Some incentives for motivating patients to participate in these meetings may be considered in future 
studies. Third, all the patients recruited in this trial are ethnic Chinese, hence the findings may not be directly 
generalizable to other ethnic groups. Future trials on other populations, especially those in the western world, 
are warranted.
In conclusion, the “Moving Bright, Eating Smart” program could modify CRC survivors’ dietary habits. 
Further work is required to assess if this intervention program could also significantly increase PA levels, espe-
cially in those with low baseline levels. Our findings are essential for the design of a larger definitive RCT in the 
future, which would determine the effects of behavioral interventions in reducing CRC recurrence and mortality 
of CRC survivors.
Materials and Methods
This was a multi-center RCT with a 2 × 2 factorial design comparing dietary and PA interventions with usual 
care in adult Chinese CRC survivors. Details of the trial protocol have been published elsewhere21. The study 
protocol and informed consent forms were approved by the by the Institutional Review Board of the Hong Kong 
West Cluster, the Hospital Authority in Hong Kong (Reference number: UW 12-478) and site-specific approval 
provided by other participating centres (Island East reference number: HKEC 2012-068; and Kowloon West ref-
erence number: KW/EX-13-002 (59-02)). The RCT has been registered with ClinicalTrials.gov (NCT01708824) 
on 11/10/2012. Informed consent was obtained from all participants. All methods were performed in accordance 
with the relevant guidelines and regulations.
Patient recruitment. We planned to recruit 224 patients with histologically confirmed CRC, aged ≥18 
years and within one year of completion of main cancer treatment from the surgical and oncological departments 
of four public hospitals in Hong Kong. The sample size was tailored to the assessment of intervention effects on 
the percentage of patients reaching the corresponding dietary or PA targets. Specifically, for assessing the effect of 
dietary interventions on the dietary targets, we assumed that 10% of the patients not receiving the interventions 
would achieve their required targets. We also assumed that 25% of those who received the interventions would 
meet the targets, i.e. an effect size of 15%. With a power of 80% and a significance level of 5%, 200 patients were 
required. Using the same criteria, the assessment of PA interventions on the PA targets would need 200 patients. 
Assuming a 10% dropout rate, we aimed to recruit 224 patients (56 per group).
To identify eligible patients, a colorectal surgeon (JHWC) reviewed the medical records of CRC patients from 
the participating hospitals within the study period. Potentially eligible patients were invited to be assessed by a 
validated food frequency questionnaire (FFQ) and the Global Physical Activity Questionnaire (GPAQ) in their 
next clinic follow-up visits22,23. Those who had already met the dietary and/or PA targets (defined below) as 
reflected by the FFQ and GPAQ were excluded, while those with confirmed eligibility were asked to provide writ-
ten informed consent for study participation.
Consented eligible patients were allocated to either Group A (dietary and PA interventions), Group B (dietary 
only), Group C (PA only), or Group D (usual care without intervention) in equal allocations using a randomi-
zation schedule generated before patient recruitment by staff not involved in the study. We used block random-
ization with randomly selected block-sizes between 8 and 16. Another staff not involved in the study kept the 
schedule and was phoned for group allocation when a patient was recruited.
Interventions. The intervention program was based on the Theory of Planned Behavior (TPB) and the 
Health Action Process Approach (HAPA)24,25. Patients allocated to Groups A, B and C received the interventions 
for 12 months and were followed for another 12 months.
The interventions included individual face-to-face motivational interviews (two sessions for Groups A and 
B and one session for Group C), fortnightly motivational phone calls, mailed monthly stage-of-change matched 
educational pamphlets, mailed quarterly newsletters, and quarterly group meetings. A staggered approach was 
adopted to change the patients’ dietary habits: patients receiving dietary interventions were asked to gradually 
reduce their intake of RPM and to replace them with other protein sources. Once in the HAPA “action stage” for 
RPM intake for one month, the patients were asked to gradually reduce their intake of RG and replace them with 
whole grains. Throughout the intervention period, the patients self-monitored their changes in intakes of RPM, 
RG and whole grains by completing monthly diary logs. Similarly, patients receiving PA interventions were asked 
to progressively increase their PA levels to 60 minutes of moderate-to-vigorous intensity PA (MVPA) 5 days a 
week. They were provided with pedometers and monthly PA logs for tracking their changes in PA. Patients in 
Group A received an integrated version of both dietary and PA interventions rather than two separate interven-
tions to avoid duplicated information and intervention overload.
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Patients in the usual care group received 5 pamphlets by post at regular intervals in the first 12 months. These 
contained general health advice that encouraged healthy lifestyles by eating a wide variety of food, more fruit and 
vegetables, increasing PA levels, quitting smoking and avoiding alcohol abuse. Such information was obtained 
from public sources including the websites of the World Health Organization and the Department of Health in 
Hong Kong.
Outcome assessment. Patients were assessed before interventions/usual care (baseline) and at every 6 
months for 24 months. All outcomes were assessed by staff blinded to the patients’ group allocation.
The primary outcomes included whether the patients could achieve four behavioral targets: (i) RPM target: 
weekly intake of <5 servings, including <2 servings of processed meat, (ii) RG target: daily intake <2 servings, 
(iii) PA general health target: 30 minutes of MVPA 5 days a week, and (iv) PA cancer outcome target: 60 min-
utes of MVPA 5 days a week. The dietary outcomes were assessed by FFQ, while PA (MVPA) was measured by 
an accelerometer using standard validated protocols19,26. The changes in these measures from baseline to the 
follow-up assessment time-points were considered as secondary efficacy outcomes. Patients’ compliance and side 
effects from the interventions, including dietary deficiency, dietary-associated anemia and PA-associated injuries 
were also examined21.
Statistical analysis. The primary outcomes of meeting the behavioral targets were analyzed based on the 
intention-to-treat principle. Patients with missing outcome measures considered not achieving the corresponding 
targets. To assess the effects of the dietary and PA interventions, generalized mixed effects models with logit link 
were used with adjustment for the corresponding baseline value, stoma status and study center. The differences 
in the effects of the dietary interventions (on the outcomes) between patients receiving and those not receiving 
PA interventions, and the differences in the effects of dietary and PA interventions over time were assessed by 
interaction terms. If they were not statistically significant, the overall effects of dietary and PA interventions were 
estimated. Otherwise, linear contrasts were used to estimate the intervention effects for different groups or time 
points. To deal with the potential problem due to multiple time-points comparison, we used an overall p-value 
to control multiplicity. That is, if the overall p-value was considered as insignificant, none of the corresponding 
multiple time-points comparisons would be considered as significant whether or not their p-values were consid-
ered as significant at the same nominal level of significance. Moreover, we also applied the Holm’s procedure to 
adjust the p-values for correcting the multiple comparisons27. The analysis was repeated by imputing the missing 
outcome measures using multiple imputation.
For the analysis of the changes in the dietary consumption and PA levels, we only included those patients 
with observed data. Linear mixed effects models were used to estimate the dietary and PA effects after adjusting 
for the baseline value, stoma status and study center. Interaction effects were assessed as in the primary anal-
ysis. Changes in caloric intake, protein intake and hemoglobin level were also evaluated for any side effects. 
Since some participants already met the PA cancer outcome target at baseline, i.e., had ≥300 minutes/week of 
accelerometer-assessed MVPA, a subgroup analysis was conducted after removing these patients.
All estimates were accompanied with 95% confidence intervals (CI), and 5% significance level was used in all 
statistical tests. All statistical analyses were conducted in SAS version 9.4.
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